Tag: TRI

INTEGRA AND SHOSHONE-PAIUTE TRIBES ESTABLISH HISTORIC RELATIONSHIP AGREEMENT

TSXV: ITR; NYSE American: ITRG www.integraresources.com VANCOUVER, BC, Aug. 15, 2025 /PRNewswire/ - Integra Resources Corp. ("Integra" or the "Company") (TSXV: ITR) (NYSE American: ITRG) is pleased...

INTEGRA AND SHOSHONE-PAIUTE TRIBES ESTABLISH HISTORIC RELATIONSHIP AGREEMENT

TSXV: ITR; NYSE American: ITRG www.integraresources.com VANCOUVER, BC, Aug. 15, 2025 /CNW/ - Integra Resources Corp. ("Integra" or the "Company") (TSXV: ITR) (NYSE American: ITRG) is pleased...

Dried Plasma Innovation Addresses Critical Global Need

Velico's FrontlineODP™ Spray Dried Plasma Achieves Key Milestone with First-in-Human Safety Trial BEVERLY, Mass., Aug. 14, 2025 /PRNewswire/ -- Trauma doesn't wait, and neither should...

Zeekr Group Reports Second Quarter 2025 Unaudited Financial Results

HANGZHOU, China, Aug. 14, 2025 /PRNewswire/ -- ZEEKR Intelligent Technology Holding Limited ("Zeekr Group" or the "Company") (NYSE: ZK), the world's leading premium new...

HopeAI Showcases AI-Powered Synthetic Data to Speed Up Cancer Drug Trials at ASCO 2025

NEW YORK, Aug. 13, 2025 /PRNewswire/ -- HopeAI , a Mayo Clinic Platform Accelerate company, is advancing how cancer clinical trials are designed and...

HopeAI Joins Mayo Clinic Platform to Transform the Future of Drug Development with AI

NEW YORK, Aug. 12, 2025 /PRNewswire/ -- HopeAI, an emerging leader in applying artificial intelligence (AI) to accelerate new drug development, has officially joined...

Ascletis Announces ASC47, a Muscle-Preserving Weight Loss Drug Candidate for Treatment of Obesity, Demonstrated Greater Efficacy with Tirzepatide than Semaglutide in a Preclinical Model

- The combination of ASC47 low dose with tirzepatide in diet-induced obese (DIO) mice resulted in an 87% greater reduction in...

Data Published in The Laryngoscope shows INO-3107 Resulted in Long-Term Surgery Reduction in Recurrent Respiratory Papillomatosis (RRP)

Retrospective trial showed Overall Response Rate (ORR) improved to 86% at the end of the second 12-month period (Year 2) compared to 72% observed...

Novartis announces both ianalumab Phase III clinical trials met primary endpoint in patients with Sjögren’s disease

Ad hoc announcement pursuant to Art. 53 LR NEPTUNUS-1 and NEPTUNUS-2 are the first ever global Phase III trials to demonstrate statistically significant reduction in...

Akeso Announces First Patient Dosed in Phase III Trial of Ivonescimab as Consolidation Therapy for Limited-Stage SCLC After Definitive Radiotherapy

HONG KONG, Aug. 10, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced that the first patient has been dosed in its multicenter,...

Cardio Partners Announces the Acquisition of RescueStat

DUBLIN, Ohio, Aug. 8, 2025 /PRNewswire/ -- Cardio Partners, Inc., a division of Sarnova, HC LLC and a leading provider in emergency readiness solutions,...

Boralex annonce un résultat d’exploitation du deuxième trimestre comparable à celui de 2024 et poursuit activement ses activités de développement et de construction de...

MONTRÉAL, 08 août 2025 (GLOBE NEWSWIRE) -- Boralex inc. (« Boralex » ou la « Société ») (TSX : BLX) annonce ses résultats pour le deuxième trimestre de l'exercice 2025.

D-Link Unveils Next-Generation Wi-Fi 7 Routers to Redefine Home and Small Business Networking

TAIPEI, Aug. 7, 2025 /PRNewswire/ -- D-Link Corporation (TWSE: 2332), a global leader in networking solutions, today introduced its next-generation Wi-Fi 7 router lineup,...

D-Link Unveils Next-Generation Wi-Fi 7 Routers to Redefine Home and Small Business Networking

TAIPEI, Aug. 7, 2025 /PRNewswire/ -- D-Link Corporation (TWSE: 2332), a global leader in networking solutions, today introduced its next-generation Wi-Fi 7 router lineup,...

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Phone

This field is for validation purposes and should be left unchanged.

HomeTagsTRI

CST Tires Showcases Lightweight Innovation at 2026 China International Bicycle Expo

PICS INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against PicS N.V. and Announces Opportunity for Investors with Substantial Losses...

JEF INVESTIGATION: Robbins Geller Rudman & Dowd LLP Launches Investigation into Jefferies Financial Group, Inc. and Encourages Investors and Potential Witnesses to Contact Law...

Tag: TRI

INTEGRA AND SHOSHONE-PAIUTE TRIBES ESTABLISH HISTORIC RELATIONSHIP AGREEMENT

INTEGRA AND SHOSHONE-PAIUTE TRIBES ESTABLISH HISTORIC RELATIONSHIP AGREEMENT

Dried Plasma Innovation Addresses Critical Global Need

Zeekr Group Reports Second Quarter 2025 Unaudited Financial Results

HopeAI Showcases AI-Powered Synthetic Data to Speed Up Cancer Drug Trials at ASCO 2025

HopeAI Joins Mayo Clinic Platform to Transform the Future of Drug Development with AI

Ascletis Announces ASC47, a Muscle-Preserving Weight Loss Drug Candidate for Treatment of Obesity, Demonstrated Greater Efficacy with Tirzepatide than Semaglutide in a Preclinical Model

Data Published in The Laryngoscope shows INO-3107 Resulted in Long-Term Surgery Reduction in Recurrent Respiratory Papillomatosis (RRP)

Novartis announces both ianalumab Phase III clinical trials met primary endpoint in patients with Sjögren’s disease

Akeso Announces First Patient Dosed in Phase III Trial of Ivonescimab as Consolidation Therapy for Limited-Stage SCLC After Definitive Radiotherapy

Cardio Partners Announces the Acquisition of RescueStat

Boralex annonce un résultat d’exploitation du deuxième trimestre comparable à celui de 2024 et poursuit activement ses activités de développement et de construction de...

D-Link Unveils Next-Generation Wi-Fi 7 Routers to Redefine Home and Small Business Networking

D-Link Unveils Next-Generation Wi-Fi 7 Routers to Redefine Home and Small Business Networking

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us